The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Blockers of sodium and calcium entry protect axons from nitric oxide‐mediated degeneration
Abstract
Axonal degeneration can be an important cause of permanent disability in neurological disorders in which inflammation is prominent, including multiple sclerosis and Guillain–Barré syndrome. The mechanisms responsible for the degeneration remain unclear, but it is likely that axons succumb to factors produced at the site of inflammation, such as nitric oxide (NO). We previously have shown that axons exposed to NO in vivo can undergo degeneration, especially if the axons are electrically active during NO exposure. The axons may degenerate because NO can inhibit mitochondrial respiration, leading to intraaxonal accumulation of Na+ and Ca 2+ ions. Here, we show that axons can be protected from NO‐mediated damage using low concentrations of Na+ channel blockers, or an inhibitor of Na+/Ca 2+ exchange. Our findings suggest a new strategy for axonal protection in an inflammatory environment, which may be effective in preventing the accumulation of permanent disability in patients with neuroinflammatory disorders. Ann Neurol 2003
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Ebers, G. C. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03334-0 · Cited by 2,073
Paty, D. W., Li, D. K. B., the UBC MS/MRI Study Group, & the IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.662 · Cited by 1,967
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
Amiloride and its analogs as tools in the study of ion transport
Kleyman, T. R., & Cragoe, E. J. (1988) · The Journal of Membrane Biology · doi:10.1007/bf01871102 · Cited by 1,140
Kappos, L. (1998) · The Lancet · doi:10.1016/s0140-6736(98)10039-9 · Cited by 936
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum
Shibuki, K., & Okada, D. (1991) · Nature · doi:10.1038/349326a0 · Cited by 871
Oxidative Stress in Brain Ischemia
Love, S. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00214.x · Cited by 685
Stys, P., Waxman, S., & Ransom, B. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00430.1992 · Cited by 662
Malinski, T., Bailey, F., Zhang, Z. G., & Chopp, M. (1993) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1993.48 · Cited by 625
Demyelination: The Role of Reactive Oxygen and Nitrogen Species
Smith, K. J., Kapoor, R., & Felts, P. A. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00212.x · Cited by 600
Self-citationInduction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
Bö, L., Dawson, T. M., Wesselingh, S., Möurk, S., Choi, S., Kong, P. A., Hanley, D., & Trapp, B. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360515 · Cited by 567
Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
Davie, C. A., Hawkins, C. P., Barker, G. J., Brennan, A., Tofts, P. S., Miller, D. H., & McDonald, W. I. (1994) · Brain · doi:10.1093/brain/117.1.49 · Cited by 534
Bolaños, J. P., Almeida, A., Stewart, V., Peuchen, S., Land, J. M., Clark, J. B., & Heales, S. J. R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68062227.x · Cited by 519
Brück, W., Bitsch, A., Kolenda, H., Brück, Y., Stiefel, M., & Lassmann, H. (1997) · Annals of Neurology · doi:10.1002/ana.410420515 · Cited by 519
Progressive cerebral atrophy in multiple sclerosis A serial MRI study
Losseff, N. A., Wang, L., Lai, H. M., Yoo, D. S., Gawne-Cain, M. L., McDonald, W. I., Miller, D. H., & Thompson, A. J. (1996) · Brain · doi:10.1093/brain/119.6.2009 · Cited by 479
Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results
Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group* (2001) · Neurology · doi:10.1212/wnl.56.11.1496 · Cited by 475
Schnell, L., Fearn, S., Klassen, H., Schwab, M. E., & Perry, V. H. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00792.x · Cited by 410
Davie, C. A., Barker, G. J., Webb, S., Tofts, P. S., Thompson, A. J., Harding, A. E., McDonald, W. I., & Miller, D. H. (1995) · Brain · doi:10.1093/brain/118.6.1583 · Cited by 377
Electrically active axons degenerate when exposed to nitric oxide
Smith, K. J., Kapoor, R., Hall, S. M., & Davies, M. (2001) · Annals of Neurology · doi:10.1002/ana.96 · Cited by 320
Self-citationA comparison of the pathology of primary and secondary progressive multiple sclerosis
Revesz, T., Kidd, D., Thompson, A. J., Barnard, R. O., & McDonald, W. I. (1994) · Brain · doi:10.1093/brain/117.4.759 · Cited by 293
Stys, P. K. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199801000-00002 · Cited by 287
Akopov, S. E., Simonian, N. A., & Grigorian, G. S. (1996) · Stroke · doi:10.1161/01.str.27.10.1739 · Cited by 245
Trebst, C., Lykke Sørensen, T., Kivisäkk, P., Cathcart, M. K., Hesselgesser, J., Horuk, R., Sellebjerg, F., Lassmann, H., & Ransohoff, R. M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63017-9 · Cited by 242
Spinal cord atrophy and disability in MS: A longitudinal study
Stevenson, V. L., Leary, S. M., Losseff, N. A., Parker, G. J. M., Barker, G. J., Husmani, Y., Miller, D. H., & Thompson, A. J. (1998) · Neurology · doi:10.1212/wnl.51.1.234 · Cited by 229
Reactive Nitrogen Intermediates in Human Neuropathology: An Overview
Brosnan, C. F., Battistini, L., Raine, C. S., Dickson, D. W., Casadevall, A., & Lee, S. C. (1994) · Developmental Neuroscience · doi:10.1159/000112102 · Cited by 209
Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration
Brown, G. C., Bolaños, J. P., Heales, S. J. R., & Clark, J. B. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11703-y · Cited by 204
Stys, P. K., Waxman, S. G., & Ransom, B. R. (1991) · Annals of Neurology · doi:10.1002/ana.410300309 · Cited by 197
Neurodegeneration in Multiple Sclerosis: Relationship to Neurological Disability
Trapp, B. D., Ransohoff, R. M., Fisher, E., & Rudick, R. A. (1999) · The Neuroscientist · doi:10.1177/107385849900500107 · Cited by 190
Local nitric oxide production in viral and autoimmune diseases of the central nervous system.
Hooper, D. C., Ohnishi, S. T., Kean, R., Numagami, Y., Dietzschold, B., & Koprowski, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5312 · Cited by 184
Stys, P. K., Ransom, B. R., & Waxman, S. G. (1992) · Journal of Neurophysiology · doi:10.1152/jn.1992.67.1.236 · Cited by 123
Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve
Garthwaite, G., Goodwin, D. A., Batchelor, A. M., Leeming, K., & Garthwaite, J. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00447-x · Cited by 112
Waxman, S. G., Black, J. A., Ransom, B. R., & Stys, P. K. (1994) · Brain Research · doi:10.1016/0006-8993(94)91680-2 · Cited by 89
Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis
Lo, A., Black, J. A., & Waxman, S. G. (2002) · Neuroreport · doi:10.1097/00001756-200210280-00015 · Cited by 83
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Cited by
Gold, R. (2006) · Brain · doi:10.1093/brain/awl075 · Cited by 1,017
“aberrantly expressed ion channels may indeed result in axonal damage in EAE, as axonal loss is significantly reduced by pharmacological agents that reduce sodium and calcium transport/entry across the axolemma (Kapoor et al., 2003; Bechtold et al., 2004).”
BackgroundMitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
Dutta, R., McDonough, J., Yin, X., Peterson, J., Chang, A., Torres, T., Gudz, T., Macklin, W. B., Lewis, D. A., Fox, R. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20736 · Cited by 841
Axon degeneration mechanisms: Commonality amid diversity
Coleman, M. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1788 · Cited by 819
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
Nikić, I., Merkler, D., Sorbara, C., Brinkoetter, M., Kreutzfeldt, M., Bareyre, F. M., Brück, W., Bishop, D., Misgeld, T., & Kerschensteiner, M. (2011) · Nature Medicine · doi:10.1038/nm.2324 · Cited by 713
“ROS and RNS fulfill these requirements and have been implicated in axon degeneratio”
BackgroundVirtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Trapp, B. D., & Stys, P. K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70043-2 · Cited by 621
Metadata
- Authors
- Kapoor, R., Davies, M., Blaker, P. A., Hall, S. M., & Smith, K. J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2002-12-30
- Volume
- 53
- Issue
- 2
- Pages
- 174-180
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1988771698
- Cited by
- 252
- References
- 37
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.